Ingredient or product comparison
GHK-Cu for Dark Spots: Treatment Comparison
GHK-Cu Tyrosinase inhibition + dermal remodeling 1–2% topical 8–12 weeks Minimal irritation, no cytotoxicity Best balance of efficacy and safety for moderate hyperpigmentation Hydroquinone 4% Melanocyte cytotoxicity 2–4% topical (Rx) 6–10 weeks Risk of ochrono
This source-based comparison does not add ratings or recommend a winner.
- GHK-Cu
- Tyrosinase inhibition + dermal remodeling
- 1–2% topical
- 8–12 weeks
- Minimal irritation, no cytotoxicity
- Best balance of efficacy and safety for moderate hyperpigmentation
- Hydroquinone 4%
- Melanocyte cytotoxicity
- 2–4% topical (Rx)
- 6–10 weeks
- Risk of ochronosis with prolonged use
- Fastest results but requires monitoring
- Vitamin C (L-ascorbic acid)
- Antioxidant, mild tyrosinase inhibition
- 10–20% topical
- 12–16 weeks
- High irritation risk at effective doses
- Weaker effect than GHK-Cu, broader tolerance
- Azelaic acid
- Tyrosinase inhibition + anti-inflammatory
- 10–14 weeks
- Moderate irritation, safe long-term
- Effective for acne-related PIH, slower than GHK-Cu
- Kojic acid
- Tyrosinase inhibition (copper chelation)
- 1–4% topical
- Contact sensitization in 10–15%
- Similar timeline to GHK-Cu but higher allergy risk